tiprankstipranks
Addex Therapeutics (ADXN)
NASDAQ:ADXN
US Market

Addex Therapeutics (ADXN) Income Statement

Compare
69 Followers

Addex Therapeutics Income Statement

Last quarter (Q3 2024), Addex Therapeutics's total revenue was CHF53.84K, a decrease of -83.57% from the same quarter last year. In Q3, Addex Therapeutics's net income was CHF-1.53M. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
CHF 1.61MCHF 1.42MCHF 2.92MCHF 3.61MCHF 2.76M
Gross Profit
CHF -5.32MCHF -13.20MCHF -9.90MCHF -6.76MCHF 2.53M
Operating Expenses
CHF 11.89MCHF 21.94MCHF 18.42MCHF 15.86MCHF 17.37M
Depreciation and Amortization
CHF 305.95KCHF 323.14KCHF 347.61KCHF 378.75KCHF 333.84K
EBITDA
CHF -10.23MCHF -20.23MCHF -14.94MCHF -12.41MCHF -14.32M
Operating Income
CHF -10.28MCHF -20.52MCHF -15.51MCHF -12.24MCHF -14.83M
Other Income/Expenses
CHF -274.93KCHF -284.01KCHF 154.00KCHF -615.33KCHF -176.45K
Pretax Income
CHF -10.56MCHF -20.80MCHF -15.35MCHF -12.86MCHF -14.78M
Net Income
CHF -10.56MCHF -20.80MCHF -15.35MCHF -12.86MCHF -14.78M
Per Share Metrics
CHF ―CHF ―CHF ―CHF ―CHF ―
Basic EPS
CHF -0.14CHF -0.46CHF -0.45CHF -0.48CHF -0.56
Diluted EPS
CHF -0.14CHF -0.46CHF -0.45CHF -0.48CHF -0.56
Weighted Average Shares Outstanding
74.31M 45.18M 34.12M 26.68M 26.43M
Weighted Average Shares Outstanding (Diluted)
74.31M 45.18M 34.12M 26.68M 26.43M
Currency in CHF

Addex Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis